Carla Giorgetti
Via Anna Maria Mozzoni, 12
Milan, Italy
Milan, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Treatment effect of palbociclib plus endocrine therapy by prognostic and intrinsic subtype and biomarker analysis in patients with bone-only disease: a joint analysis of PALOMA-2 and PALOMA-3 clinical trials.
Journal: Breast cancer research and treatment
Published: March 25, 2020
Cyclin E1 Expression and Palbociclib Efficacy in Previously Treated Hormone Receptor-Positive Metastatic Breast Cancer.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: February 27, 2019
Overall Survival with Palbociclib and Fulvestrant in Advanced Breast Cancer.
Journal: The New England journal of medicine
Published: October 23, 2018
Predictors of prolonged benefit from palbociclib plus fulvestrant in women with endocrine-resistant hormone receptor-positive/human epidermal growth factor receptor 2-negative metastatic breast cancer in PALOMA-3.
Journal: European journal of cancer (Oxford, England : 1990)
Published: June 07, 2018
Clinical considerations of the role of palbociclib in the management of advanced breast cancer patients with and without visceral metastases.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: January 18, 2018
Palbociclib in Hormone-Receptor-Positive Advanced Breast Cancer.
Journal: The New England journal of medicine
Published: June 02, 2015
Gene expression profiling of sequential metastatic biopsies for biomarker discovery in breast cancer.
Journal: Molecular oncology
Published: November 10, 2014
An exploratory study of sunitinib in combination with docetaxel and trastuzumab as first-line therapy for HER2-positive metastatic breast cancer.
Journal: Breast (Edinburgh, Scotland)
Published: August 01, 2012
Incidence-based cost-of-illness model for metastatic breast cancer in the United States.
Journal: International journal of technology assessment in health care
Published: May 24, 2012
First-line treatment of advanced breast cancer with sunitinib in combination with docetaxel versus docetaxel alone: results of a prospective, randomized phase III study.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: February 15, 2012
Clinical and pharmacokinetic study of sunitinib and docetaxel in women with advanced breast cancer.
Journal: Breast (Edinburgh, Scotland)
Published: December 15, 2011
Showing 1-11 of 11
Last Updated: 09/26/2026